 | Up a level |
Ryom, L; Boesecke, C; Bracchi, M; Ambrosioni, J; Pozniak, A; Arribas, J; Behrens, G; Mallon, Pgm; Puoti, M; Rauch, Andri; Miro, J M; Kirk, O; Marzolini, C; Lundgren, J D; Battegay, M (2018). Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0. HIV medicine, 19(5), pp. 309-315. Blackwell Science 10.1111/hiv.12600
Ryom, L; Boesecke, C; Gisler, Valentin; Manzardo, C; Rockstroh, J K; Puoti, M; Furrer, Hansjakob; Miro, J M; Gatell, J M; Pozniak, A; Behrens, G; Battegay, M; Lundgren, J D (2015). Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV medicine, 17(2), pp. 83-88. Blackwell Science 10.1111/hiv.12322
Sambatakou, H; Dabis, F; Geffard, S; Smit, C; de Wolf, F; van der Meer, J; Peters, L; Puoti, M; Monforte, AD; Tural, C; Zinkernagel, A; Ledergerber, B; Rauch, A; de Witt, S; Suarez-Lozano, N (2012). Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration. Antiviral therapy, 17(8), pp. 1541-50. London: International Medical Press
Puoti, M; Foster, G; Wang, S; Mutimer, D; Gane, E; Moreno, C; Tsung Chang, T; Lee, SS; Marinho, R; Dufour, Jean-François; Pol, S; Hezode, C; Gordon, SC; Strasser, SI; Thuluvath, PJ; Liu, R; Pilot-Matias, T; Mensa, F (14 September 2017). High SVR Rates with 8 and 12 Weeks of Pangenotypic GlecapreviriPibrentasvir: PH2 Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis. Swiss medical weekly, 147(Suppl 225), p. 20. EMH Schweizerischer Ärzteverlag
